Asthma trials recruiting in Ohio

All Asthma trials nationally

Cities in Ohio

Recruiting trials in Ohio

• 45th Multicenter Airway Research Collaboration
  NCT07166939 · Phase: Phase 4 · Ages: 18 Years to 54 Years · Sex: All (male and female) · Ohio: Cleveland
• A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
  NCT07525375 · Phase: Phase 2 · Ages: 4 Years to 11 Years · Sex: All (male and female) · Ohio: Cincinnati
• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
  NCT06664619 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Ohio: Toledo
• A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
  NCT07556159 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female) · Ohio: Lima, Toledo
• A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
  NCT07323654 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Ohio: Toledo
• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
  NCT05757102 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Ohio: Cincinnati, Cleveland, Dayton
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
  NCT07359846 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · Ohio: Dayton
• A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
  NCT06023589 · Phase: Phase 3 · Ages: 5 Years to 11 Years · Sex: All (male and female) · Ohio: Cincinnati, Cleveland, Toledo
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
  NCT06977581 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Ohio: Toledo
• Bilevel Positive Airway Pressure (BPAP) for Severe Asthma
  NCT07582211 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years to 17 Years · Sex: All (male and female) · Ohio: Columbus
• Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
  NCT06932263 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Ohio: Toledo
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
  NCT06307665 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Ohio: Cincinnati, Columbus, Dayton, Findlay
• Humidity Asthma Interventions for Low Socioeconomic Status Children
  NCT07453667 · Phase: Not applicable (e.g. observational or device study) · Ages: Up to 18 Years · Sex: All (male and female) · Ohio: Cleveland
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Ohio: Cincinnati
• Protocol CAUSE-03 / CHEETAH
  NCT06136091 · Phase: Not specified · Ages: 6 Years to 17 Years · Sex: All (male and female) · Ohio: Cincinnati
• Registry of Asthma Characterization and Recruitment 3 (RACR3)
  NCT05272241 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Ohio: Cincinnati
• Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
  NCT07444567 · Phase: Phase 3 · Ages: 6 Years and older · Sex: All (male and female) · Ohio: Cleveland
• SMART@Home Feasibility Trial
  NCT06159127 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: All (male and female) · Ohio: Cincinnati
• Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
  NCT07228026 · Phase: Not specified · Ages: 5 Years to 100 Years · Sex: All (male and female) · Ohio: Toledo